PER Spectives

Thanks for your interest in this podcast. Please read this important program information before listening.  Episode Description In this podcast, experts Joyce O’Shaughnessy, MD; Hope S. Rugo, MD; and Matthew P. Goetz, MD, discuss innovations in targeting TROP2 in triple-negative breast cancer treatment. Learning Objectives  Upon successful completion of this activity, you should be better prepared...

Thanks for your interest in this podcast. Please read this important program information before listening.  Episode Description In this podcast, experts Hope S. Rugo, MD; and Joyce O’Shaughnessy, MD, discuss pivotal trials of antibody-drug conjugates in HR+/HER2- and triple-negative subtypes of metastatic breast cancer. Learning Objectives  Upon successful completion of this activity, you should b...

Thanks for your interest in this podcast. Please read this important program information before listening.  Episode Description In this podcast, experts Benjamin P. Levy, MD; Ticiana Leal, MD; Aaron Lisberg, MD; and Christine M. Lovly, MD, PhD, FASCO, discuss current and emerging treatment strategies targeting HER2 and TROP2 in patients with advanced or metastatic non–small cell lung cancer (NSCLC...

Thanks for your interest in this podcast. Please read this important program information before listening.  Episode Description In this podcast, experts Vinay Puduvalli, MD; Manmeet Ahluwalia, MD, MBA; Stephen Bagley, MD, MSCE; and Angela Waanders, MD, MPH, MS; discuss advancements in targeted therapies to treat adult and pediatric low- and high-grade gliomas.  Learning Objectives  Upon successful...

Thanks for your interest in this podcast. Please read this important program information before listening.  Episode Description   In this podcast, experts Mohamad Mohty, MD, PhD and Surbhi Sidana, MD discuss recent advances in treatment options for relapsed/refractory multiple myeloma (R/R MM). Learning Objectives  Upon successful completion of this activity, you should be better prepared to: Anal...

Thanks for your interest in this podcast. Please read this important program information before listening.  Episode Description In this podcast, experts Mohamad Mohty, MD, PhD and Surbhi Sidana, MD discuss recent advances in treating and managing newly diagnosed multiple myeloma (NDMM). Learning Objectives  Upon successful completion of this activity, you should be better prepared to: Analyze effi...

Thanks for your interest in this podcast. Please read this important program information before listening.  Episode Description In this podcast, experts Eileen O’Reilly, MD, and Brian Wolpin, MD, MPH, discuss current principles for molecular testing and emerging targeted therapy approaches for patients with metastatic pancreatic ductal adenocarcinoma.  Learning Objectives  Upon successful completi...

Thanks for your interest in this podcast. Please read this important program information before listening.  Episode Description In this podcast, experts Gail J. Roboz, MD; Hagop Kantarjian, MD; Catherine Lai, MD, MPH; and Amer Zeidan, MBBS, MHS; discuss current best practices and emerging strategies in acute myeloid leukemia (AML) management. Learning Objectives  Upon successful completion of this...

Thanks for your interest in this podcast. Please read this important program information before listening.  Episode Description In this podcast, experts Alex A. Adjei, MD, PhD, FACP; Sandip Patel, MD, FASCO; and Jeremy Segal, MD, PhD, discuss the emerging data and clinical strategies for targeting c-MET overexpression and MET genomic alterations in non–small cell lung cancer (NSCLC), including the...

Thanks for your interest in this podcast. Please read this important program information before listening.  Episode Description In this podcast, experts Drs Stacey Cohen, Aparna Parikh, Kanwal Raghav, and John Strickler discuss advancements in targeted therapies to treat adult metastatic colorectal cancer. Learning Objectives  Upon successful completion of this activity, you should be better prepa...

Thank you for your interest in this podcast. Please read this important program information before listening.  Episode Description In this podcast, experts Rachel N. Grisham, MD; Oladapo O. Yeku, MD, PhD, FACP; and Ramez N. Eskander, MD, explore new frontiers in the treatment of ovarian cancer, including advances in biomarker-driven decision-making, maintenance strategies, and emerging targeted th...

Thanks for your interest in this podcast. Please read this important program information before listening.  Episode Description In this podcast, experts Gabriela Hobbs, MD; John O. Mascarenhas, MD; and Naveen Pemmaraju, MD; discuss recent advances in therapies for myelofibrosis (MF), polycythemia vera (PV), and essential thrombocytopenia (ET). Learning Objectives  Upon successful completion of thi...

Thanks for your interest in this podcast. Please read this important program information before listening.  Episode Description In this podcast, experts Balazs Halmos, MD, MS; Enriqueta Felip, MD, PhD; and Julia Rotow, MD; discuss the latest evidence in managing EGFR -mutated non–small cell lung cancer (NSCLC), with a focus on personalized treatment strategies based on factors such as molecular pr...

Thanks for your interest in this podcast. Please read this important program information before listening.  Episode Description In this podcast, experts Jonathan W. Goldman, MD; Percy Lee, MD, FASTRO; Erminia Massarelli, MD, PhD, MS; and Misty D. Shields, MD, PhD; discuss recent advances and emerging approaches—including immunotherapy, DLL3-targeted agents, and antibody-drug conjugates—for patient...

Episode Description In this podcast, ALS expert Terry Heiman-Patterson, MD, discusses best practices for ALS diagnosis and use of targeted therapy. Learning Objectives  Upon successful completion of this activity, you should be better prepared to: Apply recommended diagnostic criteria and strategies to make an early, accurate diagnosis of ALS Discuss the mechanisms of action, efficacy, and safety...

Episode Description In this podcast, ALS expert clinician-researcher Richard Bedlack MD, PhD, discusses targeted therapy for ALS and the role of individualized, multidisciplinary care to optimize patient outcomes. Learning Objectives  Upon successful completion of this activity, you should be better prepared to: Discuss the mechanisms of action, efficacy, and safety of approved and emerging treatm...

Episode Description In this episode of the PER® podcast, we explore the evolving landscape of HER2- mutant non–small cell lung cancer (NSCLC)—a rare and historically difficult-to-treat subset of lung cancer. Join Millie Das, MD, from Stanford/VA Palo Alto; and Eric Kumar Singhi, MD, from The University of Texas MD Anderson Cancer Center; as they delve into emerging clinical data on next-generation...

Episode Description In this podcast, experts Andy Guinigundo, MSN, RN, CNP, ANP-BC, FAPO, and Fred Hirsch, MD, PhD, review the evolving treatment landscape for limited-stage small-cell lung cancer (LS-SCLC) and extensive-stage (ES) SCLC, including a discussion of the latest strategies for managing common and severe treatment-related adverse events. Acknowledgment of Educational Grant Support This...

Episode Description This PER® Show Me Your Care Plan!™ featured podcast brings together two medical oncologists and an oncology nurse to discuss the latest advances in the management of platinum-resistant ovarian cancer (PROC). The expert panel reviews current and emerging therapies, with a special focus on the management of adverse events associated with mirvetuximab soravtansine (MIRV) and other...